Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Cole Mercer

Study Suggests GLP-1 Drugs May Reduce the Link Between Impulsivity and Violence, as Researchers Call for More Study

Why This Matters

GLP-1 drugs are already known to do far more than regulate blood glucose and reduce body weight. Patients taking semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have consistently reported reductions in cravings for alcohol, tobacco, and food. Clinical trials have shown reductions in alcohol use disorder symptoms. A growing body of evidence points to GLP-1 receptors distributed throughout the brain in regions governing reward processing, craving, and impulse control.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.